158 related articles for article (PubMed ID: 2543535)
1. Kinetics and dynamics of enalapril in patients with liver cirrhosis.
Ohnishi A; Tsuboi Y; Ishizaki T; Kubota K; Ohno T; Yoshida H; Kanezaki A; Tanaka T
Clin Pharmacol Ther; 1989 Jun; 45(6):657-65. PubMed ID: 2543535
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses.
Gardner SY; Atkins CE; Sams RA; Schwabenton AB; Papich MG
J Vet Intern Med; 2004; 18(2):231-7. PubMed ID: 15058776
[TBL] [Abstract][Full Text] [Related]
3. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of enalapril in normal volunteers.
Ishizaki T; Baba T; Murabayashi S; Kubota K; Hara K; Kurimoto F
J Cardiovasc Pharmacol; 1988; 12(5):512-9. PubMed ID: 2468049
[TBL] [Abstract][Full Text] [Related]
4. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
Ajayi AA; Hockings N; Reid JL
Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047
[TBL] [Abstract][Full Text] [Related]
5. Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment.
Lees KR; Reid JL
Clin Pharmacol Ther; 1987 Jun; 41(6):597-602. PubMed ID: 3034468
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence study of two enalapril maleate tablet formulations in healthy male volunteers. Pharmacokinetic versus pharmacodynamic approach.
Ribeiro W; Muscará MN; Martins AR; Moreno H; Mendes GB; de Nucci G
Eur J Clin Pharmacol; 1996; 50(5):399-405. PubMed ID: 8839663
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Giusti A; Uhr MR
Arzneimittelforschung; 2002; 52(4):233-42. PubMed ID: 12040965
[TBL] [Abstract][Full Text] [Related]
8. The effect of renal function on enalapril kinetics.
Lowenthal DT; Irvin JD; Merrill D; Saris S; Ulm E; Goldstein S; Hichens M; Klein L; Till A; Harris K
Clin Pharmacol Ther; 1985 Dec; 38(6):661-6. PubMed ID: 2998676
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
Baba T; Murabayashi S; Tomiyama T; Takebe K
Br J Clin Pharmacol; 1990 Jun; 29(6):766-9. PubMed ID: 2165799
[TBL] [Abstract][Full Text] [Related]
10. Enalapril pharmacokinetics and ACE inhibition, following single and chronic oral dosing.
Edeki T; Johnston A; Li Kam Wa E; Turner P
Int J Clin Pharmacol Ther; 1994 Mar; 32(3):142-6. PubMed ID: 8205376
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays.
Arafat T; Awad R; Hamad M; Azzam R; Al-Nasan A; Jehanli A; Matalka K
J Clin Pharm Ther; 2005 Aug; 30(4):319-28. PubMed ID: 15985045
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects.
Weisser K; Schloos J; Lehmann K; Düsing R; Vetter H; Mutschler E
Eur J Clin Pharmacol; 1991; 40(1):95-9. PubMed ID: 1647954
[TBL] [Abstract][Full Text] [Related]
13. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
Reams GP; Lal SM; Whalen JJ; Bauer JH
J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
Hayes PC; Plevris JN; Bouchier IA
J Hum Hypertens; 1989 Jun; 3 Suppl 1():153-8. PubMed ID: 2550638
[TBL] [Abstract][Full Text] [Related]
15. Intrapatient comparison of acute hemodynamic, hormonal, and natriuretic responses to captopril versus enalapril in liver cirrhosis.
Ohnishi A; Ishizaki T; Murakami S; Tanaka T
Clin Pharmacol Ther; 1990 Jul; 48(1):67-75. PubMed ID: 2196147
[TBL] [Abstract][Full Text] [Related]
16. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
Johnston CI; Jackson B; McGrath B; Matthews G; Arnolda L
J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses.
Gómez-Díez M; Muñoz A; Caballero JM; Riber C; Castejón F; Serrano-Rodríguez JM
Res Vet Sci; 2014 Aug; 97(1):105-10. PubMed ID: 24972864
[TBL] [Abstract][Full Text] [Related]
18. Hormonal, blood pressure, and peritoneal transport response to short-term ACE inhibition.
Ripley EB; Gehr TW; Kish CW; Sica DA
Perit Dial Int; 1994; 14(4):378-83. PubMed ID: 7827189
[TBL] [Abstract][Full Text] [Related]
19. Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
Tarkiainen EK; Tornio A; Holmberg MT; Launiainen T; Neuvonen PJ; Backman JT; Niemi M
Br J Clin Pharmacol; 2015 Nov; 80(5):1131-8. PubMed ID: 25919042
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
Bendtsen F; Henriksen JH
J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
